Skip to main content

Day: September 21, 2023

Sensei Biotherapeutics Presents New Preclinical Data Reinforcing SNS-101 Pharmacokinetic Profile, Safety Characteristics and Mechanism of Action at the Seventh CRI-ENCI-AACR International Cancer Immunotherapy Conference

– New data from multi-dose GLP toxicology study of SNS-101 in cynomolgus monkeys further support exceptional PK and safety profile – – Mechanistic mouse data show SNS-101 drives tumor macrophages to adopt an immunostimulatory, anti-tumor phenotype – BOSTON, Sept. 21, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today will present new preclinical data from SNS-101, a clinical-stage conditionally active, human monoclonal antibody targeting the immune checkpoint VISTA (V-domain Ig suppressor of T cell activation), at the Seventh Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, held on September 20...

Continue reading

Brixton Metals Drills 855.0m of 0.52% CuEq, including 109.87m of 0.86% CuEq all within 1562.35m of 0.34% CuEq at Camp Creek Target on its Thorn Project

Figure 1Thorn Project and Copper Target Location Map with Copper Geochemistry.Figure 2Camp Creek Drill Hole Intersections at -400m Elevation Below Sea Level.Figure 3Hole THN23-261 Photograph of Mineralized Core at 955.50m Depth.Figure 4Cross Section of the Camp Creek Drill Target.Figure 5Hole THN23-261 Core Photograph at 1231.49m Depth.Figure 6Hole THN23-261 Core Photograph at 1461.50m Depth.VANCOUVER, British Columbia, Sept. 21, 2023 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce the first 2023 drill results from its Camp Creek Copper Porphyry Target on its wholly owned Thorn Project located in Northwest British Columbia, Canada. HighlightsHole THN23-261 is the longest copper interval drilled at...

Continue reading

Travere Therapeutics Announces Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI® Demonstrating Long-Term Kidney Function Preservation in IgA Nephropathy; Narrowly Missing eGFR Total Slope Endpoint versus Active Control, Irbesartan

FILSPARI® (sparsentan) achieved a clinically meaningful difference vs. irbesartan in eGFR total slope (1.0 mL/min/1.73m2 per year) [p= 0.058] and eGFR chronic slope (1.1 mL/min/1.73m2 per year) [p=0.037]. Patients treated with FILSPARI over two years exhibited one of the slowest annual rates of kidney function decline seen in a clinical trial of IgAN patients (-2.7 to -2.9 mL/min/1.73m2 per year) eGFR chronic slope was statistically significant with respect to the confirmatory endpoint for the EU All topline efficacy endpoints favored FILSPARI FILSPARI was well-tolerated with a consistent safety profile comparable to irbesartan across all clinical trials conducted to date, supporting long-term use The Company will meet with regulators and expects to submit a supplemental New Drug Application (sNDA) in 1H 2024 for full approval in the...

Continue reading

Elior North America Expands Education Segment with New Acquisition

Elior NA adds NYC-based private school dining company Cater To You Food Service to its family of companiesCater to You Food ServiceCater to You Food ServiceCharlotte, NC, Sept. 21, 2023 (GLOBE NEWSWIRE) — In its first acquisition in over five years, Elior North America enters New York City’s private school dining market with the addition of family-run firm Cater To You Food Service. This move furthers the contract food management company’s aim to expand its footprint in North America through strategic acquisitions, in addition to organic growth. “We’re thrilled to welcome another highly respected business to our family of companies,” said Olivier Poirot, president and CEO of Elior North America. “Cater To You is a trusted brand built on enduring relationships and exceptional service, and we look forward to helping accelerate...

Continue reading

Central Iron Ore Ltd. – 100% Title on British King Gold Project Secured for Registration

Figure 1Tenement map of CIO interests in the Dalot Mineral FieldFigure 2Mineral Resource within the optimised pit shellVANCOUVER, British Columbia, Sept. 21, 2023 (GLOBE NEWSWIRE) — Central Iron Ore Ltd. (CIO – TSX.V) (“CIO” or “the Company”) is pleased to announce the settlement of proceedings it commenced in the Supreme Court of Western Australia against SilverStream SEZC. The Company has held 100% beneficial ownership in its British King Mine Project since October 2020. As a result of the settlement, the Company will now be in a position to have its entire 100% ownership of the British King Gold Project registered on the title of the relevant tenements. David Deitz the CEO comments: “We are very pleased that with the resolution of tenure and registration of 100% title. CIO can continue to focus on the advancement...

Continue reading

JRL Energy Elevates its Presence on Equipment Hound B2B E-Commerce Marketplace with Premium Membership

VANCOUVER, British Columbia, Sept. 21, 2023 (GLOBE NEWSWIRE) — Interfield Global Software Inc. (NEO: IFSS) (the “Company”) is pleased to announce that its 100% owned site E-Commerce site Equipment Hound, the leading B2B e-commerce marketplace for industrial equipment, has announced that JRL Energy Inc. (“JRL Energy”), a renowned USA based mining company, has taken a significant step by joining as a premium member on the Equipment Hound platform. As a premium member, JRL Energy gains exclusive access to a range of benefits designed to enhance their ability to procure cost effective mining equipment and to monetize idle assets on the Equipment Hound platform. These benefits include priority placement in search results, advanced product showcase features, and detailed analytics tools to measure and optimize their online performance. The...

Continue reading

PolyPid Announces Successful Commercial Good Manufacturing Practice (GMP) Audit by Israeli Ministry of Health

Successful Audit of the Company’s State-of-the-Art Manufacturing Facility Represents a Key Milestone Toward Plan to Commercialize D-PLEX₁₀₀ Globally PETACH TIKVA, Israel, Sept. 21, 2023 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Israeli Ministry of Health has completed a successful Good Manufacturing Practice (GMP) audit of the Company’s manufacturing facility without any critical or major findings. The audit was conducted as part of the Ministry of Health’s routine evaluation of PolyPid’s manufacturing process for D-PLEX100. The audit concluded that PolyPid’s manufacturing facility, process and quality system conform to the requirements of current GMP for medicinal products. This audit is also...

Continue reading

FactSet Reports Results for Fourth Quarter 2023

Q4 GAAP revenues of $535.8 million, up 7.3% from Q4 2022; Fiscal 2023 GAAP revenues of $2,086 million, up 13.1% from fiscal 2022 Organic Q4 ASV plus professional services of $2.2 billion, up 7.1% year over year Q4 GAAP operating margin of 21.9%, down 460 bps year over year, and adjusted operating margin of 33.6%, up 210 bps from the prior year; Fiscal 2023 GAAP operating margin of 30.2%, increased 440 bps year over year, and adjusted operating margin of 36.2%, increased 230 bps over the prior year Q4 GAAP diluted EPS of $1.68, down 37.5% from the prior year, and adjusted diluted EPS of $2.93, down 6.4% year over year; Fiscal 2023 GAAP diluted EPS of $12.03, increased 17.4% from the prior year, and adjusted diluted EPS of $14.55, increased 8.3% year over year FactSet is providing fiscal 2024 guidance, with expected ASV plus professional...

Continue reading

Robex Resources Inc. Announces Management and Board Changes

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES QUEBEC CITY, Sept. 21, 2023 (GLOBE NEWSWIRE) — Robex Resources Inc. (TSXV: RBX) (“Robex” or the “Company”) announces management changes, effective as of September 21st, 2023. Since the beginning of their first investment in Robex in 2013, the Cohen family members supported the Company by developing and operating the Nampala mine in Mali. They have been constantly engaged in operating within the industry standard thanks to their key executive positions, and long-term financial backing. They have been committed to deliver external growth strategy with the business combination with Sycamore Mining Limited in 2022. The past two years have been transformational for the Company with (i) the integration of Sycamore and teams, and (ii) the...

Continue reading

Brightstar Capital Partners Acquires Douglas Products, Manufacturer and Marketer in Global Agricultural Production and Structural Pest Control

NEW YORK and LIBERTY, Mo., Sept. 21, 2023 (GLOBE NEWSWIRE) — Brightstar Capital Partners (“Brightstar”), a private equity firm focused on partnering with families, founders, entrepreneurs, and management teams, today announced that it has acquired Douglas Products and Packaging Company, LLC (“Douglas” or the “Company”), a specialty products manufacturer and marketer of high-quality brands in the global agriculture production and structural pest control markets. Brightstar will partner with CEO Wes Long and Douglas’ management team to grow and expand operations. Terms of the private transaction were not disclosed. For more than 100 years, Douglas has helped protect food, property and quality of life. Through two highly recognizable brands, ProFume and Vikane, Douglas provides solutions to mitigate endemic pest problems that otherwise...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.